Patent classifications
C07C69/34
Odorless Active Agents
Disclosed are cyclopentene compounds and compositions containing one or more odorless lipophilic compounds cyclopentene compounds. The compositions can be applied to scalp where they stimulate hair follicles resulting in hair growth and visibly improved human hair.
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
Indole analogs as 5-oxo-ETE receptor antagonists and method of use thereof
This invention relates to novel pharmaceutically-useful compounds, to methods for their preparation, and to pharmaceutical compositions and therapeutic methods for treating certain conditions.
Indole analogs as 5-oxo-ETE receptor antagonists and method of use thereof
This invention relates to novel pharmaceutically-useful compounds, to methods for their preparation, and to pharmaceutical compositions and therapeutic methods for treating certain conditions.
MEDIUM CHAIN FATTY ACID ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL AND COMPOSITIONS AND METHODS FOR USING SAME
Aspects of the present disclosure include fatty acid -hydroxyester compounds (e.g., fatty acid esters of -hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid -hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
MEDIUM CHAIN FATTY ACID ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL AND COMPOSITIONS AND METHODS FOR USING SAME
Aspects of the present disclosure include fatty acid -hydroxyester compounds (e.g., fatty acid esters of -hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid -hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID, PRODUCTION THEREOF AND USE THEREOF AS PLASTICIZERS
Tetraisopentyl esters of butanetetracarboxylic acid are useful as plasticizers or as part of a plasticizer composition for polymers. A process for the production thereof, plasticizer compositions containing the tetraisopentyl esters of butanetetracarboxylic acid, and plastics compositions containing the tetraisopentyl esters of butanetetracarboxylic acid are also provided.
TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID, PRODUCTION THEREOF AND USE THEREOF AS PLASTICIZERS
Tetraisopentyl esters of butanetetracarboxylic acid are useful as plasticizers or as part of a plasticizer composition for polymers. A process for the production thereof, plasticizer compositions containing the tetraisopentyl esters of butanetetracarboxylic acid, and plastics compositions containing the tetraisopentyl esters of butanetetracarboxylic acid are also provided.
TETRAISOPENTYL ESTERS OF BUTANETETRACARBOXYLIC ACID HAVING A HIGH PROPORTION OF 3-METHYLBUTYL RADICALS
Tetraisopentyl esters of butanetetracarboxylic acid are useful as plasticizers or as part of a plasticizer composition for polymers, A process for the production thereof, plasticizer compositions containing the tetraisopentyl esters of butanetetracarboxylic acid, and plastics compositions containing the tetraisopentyl esters of butanetetracarboxylic acid are also provided,